T.M.C. Industrial PCL (BKK:TMC)

Marinus Pharmaceuticals Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	76.37	81.98	86.73	101.55	3.21	15.58
Short-Term Investments	274.71	274.61	300	300	-	-
Cash & Short-Term Investments	351.08	356.59	386.73	401.55	3.21	15.58
Cash Growth	-7.94%	-7.80%	-3.69%	12418.51%	-79.41%	58.92%
Accounts Receivable	23.16	38.08	54.87	41.45	32.96	36.96
Other Receivables	3.47	3.51	0.76	1.62	0.25	0.26
Receivables	26.63	41.59	55.63	43.07	33.21	37.23
Inventory	98.45	90.84	85.31	122.7	107.16	74.83
Prepaid Expenses	1.6	1.4	2.26	0.62	0.3	0.39
Other Current Assets	-	0.05	-	0.93	0.51	0.85
Total Current Assets	477.76	490.48	529.93	568.87	144.39	128.87
Property, Plant & Equipment	153.62	155.7	153.33	142.15	165.07	572.98
Long-Term Investments	19.48	19.48	17.32	18.36	20	20
Other Intangible Assets	8.57	8.41	7.52	0.33	0.42	0.86
Other Long-Term Assets	14.55	10.49	27.74	4.82	379.24	4.02
Total Assets	673.97	684.56	735.84	734.53	709.12	726.73
Accounts Payable	22.04	29.78	25.43	44.76	33.07	47.21
Accrued Expenses	7.06	5.09	5.2	14.1	2.79	5.15
Short-Term Debt	-	-	-	-	205.47	188
Current Portion of Long-Term Debt	-	-	-	-	39	40
Current Portion of Leases	2.41	2.34	1.8	0.37	0.55	0.78
Current Income Taxes Payable	-	-	1.64	-	-	-
Current Unearned Revenue	11.52	7.52	27.33	34.16	37.49	12.16
Other Current Liabilities	4.26	5.12	8.69	7.24	23.58	21.57
Total Current Liabilities	47.29	49.86	70.09	100.63	341.94	314.88
Long-Term Leases	10.08	10.86	11	-	0.37	1.28
Other Long-Term Liabilities	0.67	0.67	0.19	0.19	0.19	0.19
Total Liabilities	86.72	89.68	118.81	139.37	380.59	356.51
Common Stock	458.77	458.77	458.77	458.77	458.77	458.77
Additional Paid-In Capital	-	0	0	0	0	0
Retained Earnings	121.35	128.98	151.12	136.39	-130.25	-88.55
Comprehensive Income & Other	7.13	7.13	7.13	-	-	-
Total Common Equity	587.25	594.88	617.03	595.16	328.52	370.22
Shareholders' Equity	587.25	594.88	617.03	595.16	328.52	370.22
Total Liabilities & Equity	673.97	684.56	735.84	734.53	709.12	726.73
Total Debt	12.49	13.2	12.8	0.37	245.38	230.06
Net Cash (Debt)	338.59	343.39	373.93	401.18	-242.18	-214.48
Net Cash Growth	-8.28%	-8.17%	-6.79%	-	-	-
Net Cash Per Share	0.74	0.75	0.76	0.87	-0.53	-0.47
Filing Date Shares Outstanding	458.77	458.77	458.77	458.77	458.77	458.77
Total Common Shares Outstanding	458.77	458.77	458.77	458.77	458.77	458.77
Working Capital	430.47	440.62	459.84	468.23	-197.56	-186.01
Book Value Per Share	1.28	1.30	1.34	1.30	0.72	0.81
Tangible Book Value	578.69	586.47	609.51	594.84	328.1	369.36
Tangible Book Value Per Share	1.26	1.28	1.33	1.30	0.72	0.81
Land	-	91.28	91.28	91.28	91.28	292.03
Buildings	-	101.87	91.6	91.6	90.24	313.27
Machinery	-	310.09	320.9	320.79	351.33	408.37
Construction In Progress	-	0.21	3.72	-	-	1.5

Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.